Safety Profile for Novel CGRP Beats Standard of Care Safety Profile for Novel CGRP Beats Standard of Care

The investigative oral chronic migraine therapy atogepant showed fewer side effects than standard of care treatment and a similar hepatic function profile.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news